• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Replacement of animals in manufacture and control of vaccines.

作者信息

Hennessen W

出版信息

Dev Biol Stand. 1980;45:163-73.

PMID:6772505
Abstract

The first vaccines were obtained from animals infected with the vaccine viruses. Bacterial vaccines were derived from culture media prepared from animal tissues. In some cases the principles of manufacture remained unchanged for more than a century, the methods only were refined. Animal cell culture was not introduced into vaccine production until the second half of of this century. After more than 25 years the search for non-animal substrates and their improvement still goes on. Control of vaccines lagged behind this progress. After a period of no control for the early vaccines, animal tests enabled immunologists to measure safety and potency, thus eliminating the disasters attributable to unsafe products or failures in protection. In vitro methods of control led to a better understanding of the immunology of vaccines. Replacement of animals in manufacture is now to be paralleled by their replacement in control. This will require courage from both the manufacturer and the controller.

摘要

相似文献

1
Replacement of animals in manufacture and control of vaccines.
Dev Biol Stand. 1980;45:163-73.
2
Tests for RNA tumor viruses in cell substrates used in virus vaccine production.用于病毒疫苗生产的细胞基质中RNA肿瘤病毒的检测。
Dev Biol Stand. 1976;37:229-34.
3
The titration of clostridial toxoids and antisera in cell culture.
Dev Biol Stand. 1986;64:129-36.
4
Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation.兽用疫苗:体外——国际兽用行业试验替代组织
Dev Biol Stand. 1999;101:261-6.
5
[Progress in the replacement of animal experiments in the quality control of clostridial vaccines].[破伤风疫苗质量控制中动物实验替代方法的研究进展]
Dtsch Tierarztl Wochenschr. 2002 Apr;109(4):172-7.
6
Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.用于细胞生长及病毒/病毒疫苗生产的无血清培养基的开发——无血清培养基中所用动物产品的安全性问题
Dev Biol (Basel). 2002;111:233-57.
7
USDA: progress toward in vitro tests and other trends.美国农业部:体外试验进展及其他趋势
Dev Biol Stand. 1996;86:41-7.
8
[Novel vaccines against M. tuberculosis].[新型抗结核分枝杆菌疫苗]
Kekkaku. 2006 Dec;81(12):745-51.
9
Strategies of constructing recombinant vaccines.构建重组疫苗的策略。
Pol J Vet Sci. 2009;12(1):133-9.
10
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.单价病毒样颗粒疫苗可保护豚鼠和非人类灵长类动物免受多种马尔堡病毒感染。
Expert Rev Vaccines. 2008 May;7(4):417-29. doi: 10.1586/14760584.7.4.417.